DE2451212A1 - Mittel zur behandlung von trophischen bindegewebsveraenderungen - Google Patents

Mittel zur behandlung von trophischen bindegewebsveraenderungen

Info

Publication number
DE2451212A1
DE2451212A1 DE19742451212 DE2451212A DE2451212A1 DE 2451212 A1 DE2451212 A1 DE 2451212A1 DE 19742451212 DE19742451212 DE 19742451212 DE 2451212 A DE2451212 A DE 2451212A DE 2451212 A1 DE2451212 A1 DE 2451212A1
Authority
DE
Germany
Prior art keywords
water
carrier
canrenone
oil
connective tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742451212
Other languages
German (de)
English (en)
Inventor
Werner Dr Rer Nat Rothe
Raimund Dr Med Timmler
Heinrich Dr Rer Nat Woog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19742451212 priority Critical patent/DE2451212A1/de
Priority to GB4358375A priority patent/GB1472148A/en
Priority to NL7512464A priority patent/NL7512464A/xx
Priority to BE161272A priority patent/BE834895A/xx
Priority to FR7532868A priority patent/FR2299036A1/fr
Publication of DE2451212A1 publication Critical patent/DE2451212A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19742451212 1974-10-29 1974-10-29 Mittel zur behandlung von trophischen bindegewebsveraenderungen Pending DE2451212A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE19742451212 DE2451212A1 (de) 1974-10-29 1974-10-29 Mittel zur behandlung von trophischen bindegewebsveraenderungen
GB4358375A GB1472148A (en) 1974-10-29 1975-10-23 Pharmaceutical compositions
NL7512464A NL7512464A (nl) 1974-10-29 1975-10-24 Werkwijze voor de bereiding van een farmaceutisch preparaat.
BE161272A BE834895A (fr) 1974-10-29 1975-10-27 Compositions pharmaceutiques pour le traitement de troubles trophiques du tissu conjonctif
FR7532868A FR2299036A1 (fr) 1974-10-29 1975-10-28 Composition pour le traitement de troubles trophiques du tissu conjonctif

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742451212 DE2451212A1 (de) 1974-10-29 1974-10-29 Mittel zur behandlung von trophischen bindegewebsveraenderungen

Publications (1)

Publication Number Publication Date
DE2451212A1 true DE2451212A1 (de) 1976-05-06

Family

ID=5929402

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742451212 Pending DE2451212A1 (de) 1974-10-29 1974-10-29 Mittel zur behandlung von trophischen bindegewebsveraenderungen

Country Status (5)

Country Link
BE (1) BE834895A (enExample)
DE (1) DE2451212A1 (enExample)
FR (1) FR2299036A1 (enExample)
GB (1) GB1472148A (enExample)
NL (1) NL7512464A (enExample)

Also Published As

Publication number Publication date
FR2299036B1 (enExample) 1979-03-23
GB1472148A (en) 1977-05-04
BE834895A (fr) 1976-04-27
NL7512464A (nl) 1976-05-04
FR2299036A1 (fr) 1976-08-27

Similar Documents

Publication Publication Date Title
DE69232914T2 (de) Topische Zubereitung, die eine Suspension von festen lipidischen Teilchen enthält
AT390372B (de) Verwendung von solarfiltern zur stabilisierung und verbesserung der hautvertraeglichkeit von benzoylperoxyd enthaltenden zubereitungen zur lokalen aknebehandlung
DE69522696T2 (de) Nimesulid zur aüsserlichen anwendung
DE2757827A1 (de) Arzneipraeparate mit einem gehalt an einem isosorbid-loesungsmittelsystem
DE69202827T2 (de) Kosmetische Mittel in Form von wässerigen Organopolysiloxan-Emulsionen.
EP0540857B1 (de) Verfahren zur Herstellung von stabilen, komplexen Emulsionssystemen des Typs Wasser-Öl-Wasser und Verwendung als kosmetische Präparate
DE69410119T2 (de) Wasser-in-oel-lotion, die ein corticosteroid enthaelt
DE1467907C3 (de) Verfahren zur Herstellung von .Weich gelatinekapseln
DE4018995C2 (de) Corticoidsteroidhaltiges Mittel und Verfahren zur Verbesserung der therapeutischen Wirksamkeit von lipidlöslichen Corticosteroiden
DE3713492A1 (de) Verfahren zur herstellung einer dispersion von niosomen in einer waessrigen phase
EP4558119A2 (de) Verfahren zur herstellung einer kosmetischen wasser-in-öl-emulsion aus einer glycerin-in-öl-emulsion
DE1106455B (de) Salbengrundlage
DE69919597T2 (de) Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung
DE4121945C2 (de) Verfahren zur herstellung von stabilen, hydrophilen oder ambiphilen creme-zubereitungen, enthaltend vesikulaere bestandteile, stabile creme-zubereitungen mit vesikulaeren bestandteilen und deren verwendung
DE19630176C2 (de) Kosmetische und pharmazeutische Mittel, gebildet durch eine nach dem Phaseninversionsverfahren erzeugte W/O/W-Emulsion
DE3323833A1 (de) Etofenamat-zubereitung
EP0045008A2 (de) Verfahren zur Herstellung von pharmazeutischen und kosmetischen Dispersionen
DE3526669C2 (enExample)
DE4329379C1 (de) Gegen unreine Haut und milde Formen der Akne wirksame Zubereitungen mit einem Gehalt an Wollwachssäuren
DE69122229T2 (de) Penciclovir enthaltende pharmazeutische formulierung
EP0596953A1 (de) Emulgatorkonzentrat
DE2451212A1 (de) Mittel zur behandlung von trophischen bindegewebsveraenderungen
DE2646435A1 (de) Verfahren zur herstellung einer stabilen oel/wasser-emulsion und diese enthaltende kosmetische mittel
DE69203071T2 (de) Verfahren zur erhoehung der therapeutischen wirksamkeit fettloeslicher fungizideaus der familie der imidazole sowie mittel zur durchfuehrung dieses verfahren.
DE10211140A1 (de) Stabile Dispersionskonzentrate

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee